首页 > 最新文献

Asia-Pacific Journal of Oncology Nursing最新文献

英文 中文
Qigong in the care of breast cancer survivors with diabetes 气功在乳腺癌幸存者糖尿病护理中的应用
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100501
Pei-Shiun Chang, Dane Ceniza, Susan Storey
{"title":"Qigong in the care of breast cancer survivors with diabetes","authors":"Pei-Shiun Chang, Dane Ceniza, Susan Storey","doi":"10.1016/j.apjon.2024.100501","DOIUrl":"10.1016/j.apjon.2024.100501","url":null,"abstract":"","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100501"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001239/pdfft?md5=803719cf13bc07b0dc0776c9b8a2fee9&pid=1-s2.0-S2347562524001239-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141031005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer 非小细胞肺癌患者康复前管理的最佳证据摘要
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100516
Wenfang Wu, Huayan Li, Rongrong Fan

Objective

This study adopts an evidence-based methodology to establish a comprehensive theory foundation for preoperative prehabilitation management in non-small cell lung cancer (NSCLC) patients.

Methods

A systematic literature review linked to prehabilitation management for NSCLC patients was conducted, utilizing reputable databases such as UpToDate, BMJ Best Practice, UK NICE, SIGN, GIN, Joanna Briggs Institute Library, Cochrane Library, Web of Science, Embase, OVID evidence-based database, PubMed, Chinese Wanfang database, CNKI, CBM, ATS, BTS, AACVPR, and EACTS. The search encompassed articles, including clinical decision-making, guidelines, evidence summaries, expert consensuses, and systematic reviews, from the inception of databases up to March 31st, 2023. Two researchers performed quality assessment of the literature and subsequent evidence extraction.

Results

Nineteen articles were included, comprising five guidelines, three expert consensuses, seven systematic reviews, and four randomized controlled trials. A total of 41 pieces of evidence were summarized, addressing key aspects such as the multidisciplinary team, appropriate patient population, prehabilitation modes, timing of prehabilitation, prehabilitation assessment, prehabilitation content, quality control, and effectiveness evaluation.

Conclusions

The synthesis of the best evidence for prehabilitation management in NSCLC patients provides a solid evidence-based foundation for its implementation. It is recommended that healthcare professionals conduct thorough patient evaluations, optimize and integrate medical resources, and collaboratively engage in interdisciplinarity efforts to develop and implement personalized and multimodal prehabilitation plans.

目的本研究采用循证方法,为非小细胞肺癌(NSCLC)患者术前康复管理建立全面的理论基础。方法利用UpToDate、BMJ Best Practice、UK NICE、SIGN、GIN、Joanna Briggs Institute Library、Cochrane Library、Web of Science、Embase、OVID循证数据库、PubMed、中国万方数据库、CNKI、CBM、ATS、BTS、AACVPR和EACTS等著名数据库,对NSCLC患者术前康复管理进行系统性文献综述。检索范围包括从数据库建立之初到 2023 年 3 月 31 日的文章,包括临床决策、指南、证据摘要、专家共识和系统综述。结果共纳入 19 篇文章,包括 5 份指南、3 份专家共识、7 份系统综述和 4 份随机对照试验。共总结了 41 项证据,涉及多学科团队、合适的患者人群、康复前模式、康复前时机、康复前评估、康复前内容、质量控制和效果评估等关键方面。结论NSCLC 患者康复前管理的最佳证据综述为其实施提供了坚实的循证基础。建议医护人员对患者进行全面评估,优化和整合医疗资源,跨学科合作,制定和实施个性化、多模式的康复前计划。
{"title":"Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer","authors":"Wenfang Wu,&nbsp;Huayan Li,&nbsp;Rongrong Fan","doi":"10.1016/j.apjon.2024.100516","DOIUrl":"10.1016/j.apjon.2024.100516","url":null,"abstract":"<div><h3>Objective</h3><p>This study adopts an evidence-based methodology to establish a comprehensive theory foundation for preoperative prehabilitation management in non-small cell lung cancer (NSCLC) patients.</p></div><div><h3>Methods</h3><p>A systematic literature review linked to prehabilitation management for NSCLC patients was conducted, utilizing reputable databases such as UpToDate, BMJ Best Practice, UK NICE, SIGN, GIN, Joanna Briggs Institute Library, Cochrane Library, Web of Science, Embase, OVID evidence-based database, PubMed, Chinese Wanfang database, CNKI, CBM, ATS, BTS, AACVPR, and EACTS. The search encompassed articles, including clinical decision-making, guidelines, evidence summaries, expert consensuses, and systematic reviews, from the inception of databases up to March 31st, 2023. Two researchers performed quality assessment of the literature and subsequent evidence extraction.</p></div><div><h3>Results</h3><p>Nineteen articles were included, comprising five guidelines, three expert consensuses, seven systematic reviews, and four randomized controlled trials. A total of 41 pieces of evidence were summarized, addressing key aspects such as the multidisciplinary team, appropriate patient population, prehabilitation modes, timing of prehabilitation, prehabilitation assessment, prehabilitation content, quality control, and effectiveness evaluation.</p></div><div><h3>Conclusions</h3><p>The synthesis of the best evidence for prehabilitation management in NSCLC patients provides a solid evidence-based foundation for its implementation. It is recommended that healthcare professionals conduct thorough patient evaluations, optimize and integrate medical resources, and collaboratively engage in interdisciplinarity efforts to develop and implement personalized and multimodal prehabilitation plans.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100516"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001380/pdfft?md5=09f921044efa822b8b6922d2fd20e73d&pid=1-s2.0-S2347562524001380-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141041097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a nurse navigation program for cancer pain 针对癌症疼痛制定护士导航计划
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100528
Miyoung Yoo , Eunyoung E. Suh , Mi Jang , Sunsil Kang

Objective

Cancer pain significantly impacts the overall quality of life of cancer patients, necessitating proactive management. The manifestations of cancer pain vary individually and require tailored interventions to address each patient's unique characteristics. Therefore, this study aims to develop a nurse navigation program for cancer pain (NNP-CP) tailored to the needs of cancer patients requiring pain control, aiming to establish evidence-based clinical nursing practices and promote effective cancer pain management.

Methods

This study is a methodological research into developing a pain management program led by nurses for cancer patients requiring pain control, based on a professional navigation framework. The development of the program relied on three out of the five stages of the ADDIE (Analysis, Design, Development, Implementation, Evaluation) model.

Results

A literature review was conducted to select the content and rationale to be included in the intervention program. Publications within the last 10 years in English or Korean were identified and screened based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 literature selection flow, 17 articles were included. Standardized information regarding cancer pain control was based on the 7th edition of 'Cancer Pain Management Guidelines'. The initial draft of the pain management intervention program was developed by organizing and structuring the derived content based on the professional navigation framework. Subsequently, the final intervention program was confirmed through the review by six clinical experts specializing in cancer pain.

Conclusions

Cancer pain is a significant factor that profoundly influences the quality of life and survival duration of cancer patients. While appropriate management methods offer the prospect of control, insufficient intervention is the current reality. Through the pain management intervention program based on the expert navigation framework that promotes continuity of care and empowers the recipients, this study anticipates not only pain reduction in cancer patients but also an enhancement in their quality of life.

目标癌痛严重影响癌症患者的整体生活质量,因此需要积极治疗。癌痛的表现形式因人而异,需要针对每位患者的独特性采取量身定制的干预措施。因此,本研究旨在针对需要控制疼痛的癌症患者的需求,制定一项癌症疼痛护士导航计划(NNP-CP),旨在建立循证临床护理实践,促进有效的癌症疼痛管理。方法本研究是一项方法学研究,以专业导航框架为基础,为需要控制疼痛的癌症患者制定一项由护士主导的疼痛管理计划。该计划的开发依赖于 ADDIE(分析、设计、开发、实施、评估)模型五个阶段中的三个阶段。根据 "系统综述和元分析首选报告项目"(PRISMA)2020 文献筛选流程,对过去 10 年内的英文或韩文出版物进行了识别和筛选,共纳入 17 篇文章。癌症疼痛控制的标准化信息以第 7 版《癌症疼痛管理指南》为基础。在专业导航框架的基础上,通过对衍生内容进行组织和结构化,制定了疼痛管理干预方案的初稿。结论癌症疼痛是深刻影响癌症患者生活质量和生存期的重要因素。虽然适当的管理方法提供了控制的前景,但干预不足却是当前的现实。通过基于专家导航框架的疼痛管理干预计划,促进护理的连续性并增强受助者的能力,本研究预计不仅能减轻癌症患者的疼痛,还能提高他们的生活质量。
{"title":"Development of a nurse navigation program for cancer pain","authors":"Miyoung Yoo ,&nbsp;Eunyoung E. Suh ,&nbsp;Mi Jang ,&nbsp;Sunsil Kang","doi":"10.1016/j.apjon.2024.100528","DOIUrl":"https://doi.org/10.1016/j.apjon.2024.100528","url":null,"abstract":"<div><h3>Objective</h3><p>Cancer pain significantly impacts the overall quality of life of cancer patients, necessitating proactive management. The manifestations of cancer pain vary individually and require tailored interventions to address each patient's unique characteristics. Therefore, this study aims to develop a nurse navigation program for cancer pain (NNP-CP) tailored to the needs of cancer patients requiring pain control, aiming to establish evidence-based clinical nursing practices and promote effective cancer pain management.</p></div><div><h3>Methods</h3><p>This study is a methodological research into developing a pain management program led by nurses for cancer patients requiring pain control, based on a professional navigation framework. The development of the program relied on three out of the five stages of the ADDIE (Analysis, Design, Development, Implementation, Evaluation) model.</p></div><div><h3>Results</h3><p>A literature review was conducted to select the content and rationale to be included in the intervention program. Publications within the last 10 years in English or Korean were identified and screened based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 literature selection flow, 17 articles were included. Standardized information regarding cancer pain control was based on the 7th edition of 'Cancer Pain Management Guidelines'. The initial draft of the pain management intervention program was developed by organizing and structuring the derived content based on the professional navigation framework. Subsequently, the final intervention program was confirmed through the review by six clinical experts specializing in cancer pain.</p></div><div><h3>Conclusions</h3><p>Cancer pain is a significant factor that profoundly influences the quality of life and survival duration of cancer patients. While appropriate management methods offer the prospect of control, insufficient intervention is the current reality. Through the pain management intervention program based on the expert navigation framework that promotes continuity of care and empowers the recipients, this study anticipates not only pain reduction in cancer patients but also an enhancement in their quality of life.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100528"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001501/pdfft?md5=606358ba5112b4d73e8c3241c6c8291c&pid=1-s2.0-S2347562524001501-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141595965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence trends and spatial distribution of thyroid cancer in the Chinese female population from 1990 to 2019 1990-2019年中国女性甲状腺癌的发病趋势和空间分布
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100529
Xiaowei Qiao , Yunshang Cui , Changgeng Ma , Chunxiao Ma , Bingyu Bai , Chunping Wang

Objective

This study aimed to analyze the incidence trends and spatial distribution characteristics of thyroid cancer among Chinese females from 1990 to 2019, thereby providing a scientific foundation and data support for the development of prevention and control policies.

Methods

Thyroid cancer incidence data from the Global Burden of Disease (GBD) research and the annual report from the Chinese Tumor Registration were utilized. The standardized thyroid cancer incidence rate among Chinese females 1990 to 2019 was described to understand the changes in developmental trends. The JoinPoint Regression Model was employed using Excel 2019, GraphPad Prism 8, JoinPoint Regression Program 4.8.0.1, and ArcGIS 10.2.

Results

Thyroid cancer's standardized incidence among female Chinese continued to increase at 1.7% per year (annual average percentage change [AAPC] = 1.7, P < 0.001), and the spatial distribution was clustered. The main high-incidence areas were North, East, and Northwest China.

Conclusions

Thyroid cancer incidence in Chinese women is rapidly increasing, and its spatial distribution is concentrated. Strengthening monitoring, prevention, and control efforts in the relevant areas is warranted.

方法利用全球疾病负担(GBD)研究和中国肿瘤登记年报中的甲状腺癌发病数据,分析1990-2019年中国女性甲状腺癌的发病趋势和空间分布特征,为制定防控政策提供科学依据和数据支持。方法利用全球疾病负担研究(GBD)和中国肿瘤登记年报中的甲状腺癌发病率数据,对1990-2019年中国女性甲状腺癌发病率进行标准化描述,以了解其发展趋势变化。利用Excel 2019、GraphPad Prism 8、JoinPoint Regression Program 4.8.0.1和ArcGIS 10.2建立了JoinPoint回归模型。结果中国女性甲状腺癌的标准化发病率以每年1.7%的速度持续增长(年均百分比变化[AAPC] = 1.7,P <0.001),且空间分布呈聚集性。结论中国女性甲状腺癌发病率呈快速上升趋势,且空间分布集中。应加强相关地区的监测和防控工作。
{"title":"Incidence trends and spatial distribution of thyroid cancer in the Chinese female population from 1990 to 2019","authors":"Xiaowei Qiao ,&nbsp;Yunshang Cui ,&nbsp;Changgeng Ma ,&nbsp;Chunxiao Ma ,&nbsp;Bingyu Bai ,&nbsp;Chunping Wang","doi":"10.1016/j.apjon.2024.100529","DOIUrl":"10.1016/j.apjon.2024.100529","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to analyze the incidence trends and spatial distribution characteristics of thyroid cancer among Chinese females from 1990 to 2019, thereby providing a scientific foundation and data support for the development of prevention and control policies.</p></div><div><h3>Methods</h3><p>Thyroid cancer incidence data from the Global Burden of Disease (GBD) research and the annual report from the Chinese Tumor Registration were utilized. The standardized thyroid cancer incidence rate among Chinese females 1990 to 2019 was described to understand the changes in developmental trends. The JoinPoint Regression Model was employed using Excel 2019, GraphPad Prism 8, JoinPoint Regression Program 4.8.0.1, and ArcGIS 10.2.</p></div><div><h3>Results</h3><p>Thyroid cancer's standardized incidence among female Chinese continued to increase at 1.7% per year (annual average percentage change [AAPC] = 1.7, <em>P</em> &lt; 0.001), and the spatial distribution was clustered. The main high-incidence areas were North, East, and Northwest China.</p></div><div><h3>Conclusions</h3><p>Thyroid cancer incidence in Chinese women is rapidly increasing, and its spatial distribution is concentrated. Strengthening monitoring, prevention, and control efforts in the relevant areas is warranted.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100529"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001513/pdfft?md5=876dfedb3ca048874629cc459b4349b4&pid=1-s2.0-S2347562524001513-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141275534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and results of virtual nursing intervention for cancer patients: A systematic review and meta-analysis 针对癌症患者的虚拟护理干预的功效和结果:系统回顾和荟萃分析
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100515
Hui Fang, Yajun Sun, Dongfeng Yu, Yuhong Xu

Objective

Virtual nursing interventions, which use virtual reality and artificial intelligence technology to provide remote care for patients, have become increasingly common in cancer treatment, especially during the COVID-19 pandemic. This study was to evaluate the efficacy of virtual nursing interventions for cancer patients in contrast to conventional, in-person care.

Methods

Eight randomized controlled trials (RCTs) contrasted virtual nursing with conventional techniques that satisfied the inclusion criteria were found after a thorough search across databases including PubMed, Web of Science, CINAHL, EMBASE, the Cochrane Library, Scopus, and APA PsycINFO. RevMan 5.3 software was utilized for data analysis after the included literature's quality was assessed and the intended consequence indicators were extracted.

Results

Virtual nurse interventions enhanced the quality of life of cancer patients (standardized mean difference [SMD] = 0.22, 95% confidence interval [CI] 0.01 to 0.43, P = 0.04). Virtual nurse interventions provide cancer patients with important support, particularly when access to in-person care is limited. In light of the many demands that cancer patients have, further research is required to overcome implementation issues and provide fair access to virtual treatment.

Conclusions

All things considered, virtual nursing shows potential as an adjunctive element of all-inclusive cancer care delivery models, deserving of further investigation and thoughtful incorporation into healthcare systems.

目的利用虚拟现实和人工智能技术为患者提供远程护理的虚拟护理干预在癌症治疗中越来越常见,尤其是在 COVID-19 大流行期间。本研究旨在评估虚拟护理干预对癌症患者的疗效,并与传统的面对面护理进行对比。方法在对包括 PubMed、Web of Science、CINAHL、EMBASE、the Cochrane Library、Scopus 和 APA PsycINFO 在内的数据库进行全面检索后,找到了八项符合纳入标准的随机对照试验 (RCT),这些试验将虚拟护理与传统技术进行了对比。结果虚拟护士干预提高了癌症患者的生活质量(标准化平均差 [SMD] = 0.22,95% 置信区间 [CI] 0.01 至 0.43,P = 0.04)。虚拟护士干预为癌症患者提供了重要的支持,尤其是在亲身护理受到限制的情况下。考虑到癌症患者的诸多需求,需要进一步开展研究,以克服实施方面的问题,并提供公平的虚拟治疗机会。结论综上所述,虚拟护理显示出作为全纳癌症护理服务模式辅助元素的潜力,值得进一步研究并周到地纳入医疗保健系统。
{"title":"Efficacy and results of virtual nursing intervention for cancer patients: A systematic review and meta-analysis","authors":"Hui Fang,&nbsp;Yajun Sun,&nbsp;Dongfeng Yu,&nbsp;Yuhong Xu","doi":"10.1016/j.apjon.2024.100515","DOIUrl":"10.1016/j.apjon.2024.100515","url":null,"abstract":"<div><h3>Objective</h3><p>Virtual nursing interventions, which use virtual reality and artificial intelligence technology to provide remote care for patients, have become increasingly common in cancer treatment, especially during the COVID-19 pandemic. This study was to evaluate the efficacy of virtual nursing interventions for cancer patients in contrast to conventional, in-person care.</p></div><div><h3>Methods</h3><p>Eight randomized controlled trials (RCTs) contrasted virtual nursing with conventional techniques that satisfied the inclusion criteria were found after a thorough search across databases including PubMed, Web of Science, CINAHL, EMBASE, the Cochrane Library, Scopus, and APA PsycINFO. RevMan 5.3 software was utilized for data analysis after the included literature's quality was assessed and the intended consequence indicators were extracted.</p></div><div><h3>Results</h3><p>Virtual nurse interventions enhanced the quality of life of cancer patients (standardized mean difference [SMD] = 0.22, 95% confidence interval [CI] 0.01 to 0.43, <em>P</em> = 0.04). Virtual nurse interventions provide cancer patients with important support, particularly when access to in-person care is limited. In light of the many demands that cancer patients have, further research is required to overcome implementation issues and provide fair access to virtual treatment.</p></div><div><h3>Conclusions</h3><p>All things considered, virtual nursing shows potential as an adjunctive element of all-inclusive cancer care delivery models, deserving of further investigation and thoughtful incorporation into healthcare systems.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100515"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001379/pdfft?md5=11137c0d3437f75e98f9f1f9a9a16ad2&pid=1-s2.0-S2347562524001379-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141044609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning risk prediction model for bloodstream infections related to totally implantable venous access ports in patients with cancer 癌症患者全植入式静脉通路端口相关血流感染的机器学习风险预测模型
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-06-22 DOI: 10.1016/j.apjon.2024.100546
Fan Wang , Yanyi Zhu , Lijuan Wang , Caiying Huang , Ranran Mei , Li-e Deng , Xiulan Yang , Yan Xu , Lingling Zhang , Min Xu

Objective

This study aimed to develop and validate a machine learning-based risk prediction model for catheter-related bloodstream infection (CRBSI) following implantation of totally implantable venous access ports (TIVAPs) in patients.

Methods

A retrospective cohort study design was employed, utilizing the R software package mlr3. Various algorithms including logistic regression, naive Bayes, K nearest neighbor, classification tree, and random forest were applied. Addressing class imbalance, benchmarks were used, and model performance was assessed using the area under the curve (AUC). The final model, chosen for its superior performance, was interpreted using variable importance scores. Additionally, a nomogram was developed to calculate individualized risk probabilities, enhancing clinical utility.

Results

The study involved 755 patients across both development and validation cohorts, with a TIVAP-CRBSI rate of 14.17%. The random forest model demonstrated the highest discrimination ability, achieving a validated AUC of 0.94, which was consistent in the validation cohort.

Conclusions

This study successfully developed a robust predictive model for TIVAP-CRBSI risk post-implantation. Implementation of this model may aid healthcare providers in making informed decisions, thereby potentially improving patient outcomes.

目的 本研究旨在开发并验证一种基于机器学习的导管相关血流感染(CRBSI)风险预测模型,该模型适用于植入全植入式静脉通路端口(TIVAP)的患者。应用了多种算法,包括逻辑回归、天真贝叶斯、K 近邻、分类树和随机森林。为解决类不平衡问题,使用了基准,并通过曲线下面积(AUC)评估模型性能。最终的模型因其卓越的性能而被选中,并使用变量重要性得分进行解释。此外,还开发了一个提名图来计算个体化风险概率,从而提高临床实用性。结果该研究涉及开发和验证队列中的 755 名患者,TIVAP-CRBSI 感染率为 14.17%。随机森林模型表现出了最高的辨别能力,验证的AUC为0.94,这在验证队列中是一致的。该模型的实施可帮助医疗服务提供者做出明智的决策,从而改善患者的预后。
{"title":"Machine learning risk prediction model for bloodstream infections related to totally implantable venous access ports in patients with cancer","authors":"Fan Wang ,&nbsp;Yanyi Zhu ,&nbsp;Lijuan Wang ,&nbsp;Caiying Huang ,&nbsp;Ranran Mei ,&nbsp;Li-e Deng ,&nbsp;Xiulan Yang ,&nbsp;Yan Xu ,&nbsp;Lingling Zhang ,&nbsp;Min Xu","doi":"10.1016/j.apjon.2024.100546","DOIUrl":"10.1016/j.apjon.2024.100546","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to develop and validate a machine learning-based risk prediction model for catheter-related bloodstream infection (CRBSI) following implantation of totally implantable venous access ports (TIVAPs) in patients.</p></div><div><h3>Methods</h3><p>A retrospective cohort study design was employed, utilizing the R software package mlr3. Various algorithms including logistic regression, naive Bayes, K nearest neighbor, classification tree, and random forest were applied. Addressing class imbalance, benchmarks were used, and model performance was assessed using the area under the curve (AUC). The final model, chosen for its superior performance, was interpreted using variable importance scores. Additionally, a nomogram was developed to calculate individualized risk probabilities, enhancing clinical utility.</p></div><div><h3>Results</h3><p>The study involved 755 patients across both development and validation cohorts, with a TIVAP-CRBSI rate of 14.17%. The random forest model demonstrated the highest discrimination ability, achieving a validated AUC of 0.94, which was consistent in the validation cohort.</p></div><div><h3>Conclusions</h3><p>This study successfully developed a robust predictive model for TIVAP-CRBSI risk post-implantation. Implementation of this model may aid healthcare providers in making informed decisions, thereby potentially improving patient outcomes.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 8","pages":"Article 100546"},"PeriodicalIF":2.4,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001689/pdfft?md5=2c3c339e4e9e056c9ac7e64ef00603f0&pid=1-s2.0-S2347562524001689-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141728585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meditation for the reduction of perioperative anxiety in patients undergoing oncology surgery: A scoping review 通过冥想减轻肿瘤手术患者围手术期的焦虑:范围综述
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-06-22 DOI: 10.1016/j.apjon.2024.100544
Jennifer R. Majumdar , Cidalia J. Vital , Justin M. O'Leary , Stephen J. Yermal , John C. Welch

Objective

Patients undergoing surgery, particularly patients undergoing surgery for oncology diagnoses, experience anxiety. Surgery remains the primary treatment for many common types of cancer. One promising potential intervention to alleviate anxiety in the preoperative and postoperative period is meditation, an integrative medicine intervention. However, there remains a gap in the literature regarding the effectiveness of meditation to alleviate anxiety during the perioperative time period.

Methods

The scoping review was conducted using the Arksey and O'Malley framework to synthesize the study findings and was reported with the Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). The review included EMBASE, PubMed, Web of Science, CINAHL Plus, Scopus, and Cochrane Review databases from 2013 through 2024. All identified articles were exported to the online systematic review software, Covidence.

Results

A total of 538 initial citations were identified, 415 titles and abstracts were screened, and 83 full-text articles reviewed. Six studies were finally included. The data extracted from the literature included: study purpose, study design, sample size, preoperative or postoperative timeframe, instrument to evaluate anxiety, and conclusions.

Conclusions

For patients undergoing oncology surgery, the perioperative period can be filled with anxiety. Guided, mindfulness, and loving-kindness meditation may be helpful in reducing anxiety, particularly in patients undergoing surgery for breast cancer during the postoperative period. However, the current literature is extremely limited. Future research should expand on the preliminary effectiveness to broader populations and carefully target the highest-risk populations for the ideal time point for interventions.

目的接受手术的患者,尤其是因肿瘤诊断而接受手术的患者会感到焦虑。手术仍然是许多常见癌症的主要治疗方法。冥想是一种很有前景的潜在干预方法,可以缓解术前和术后的焦虑情绪,冥想是一种综合医学干预方法。方法该范围综述采用 Arksey 和 O'Malley 框架来综合研究结果,并按照《系统综述和元分析扩展报告首选报告项目》(Preferred Reporting Items for Systematic Review and Meta-Analyses Extension for Scoping Reviews,PRISMA-ScR)进行报告。综述包括 EMBASE、PubMed、Web of Science、CINAHL Plus、Scopus 和 Cochrane Review 数据库(从 2013 年到 2024 年)。所有确定的文章都被导出到在线系统综述软件 Covidence 中。结果 共确定了 538 篇初始引文,筛选了 415 篇标题和摘要,并审查了 83 篇全文。最终纳入了六项研究。从文献中提取的数据包括:研究目的、研究设计、样本大小、术前或术后时间范围、评估焦虑的工具以及结论。引导式冥想、正念冥想和慈爱冥想可能有助于减轻焦虑,尤其是在术后接受乳腺癌手术的患者。然而,目前的文献极其有限。未来的研究应将初步的有效性扩大到更广泛的人群,并谨慎地针对高风险人群确定干预的理想时间点。
{"title":"Meditation for the reduction of perioperative anxiety in patients undergoing oncology surgery: A scoping review","authors":"Jennifer R. Majumdar ,&nbsp;Cidalia J. Vital ,&nbsp;Justin M. O'Leary ,&nbsp;Stephen J. Yermal ,&nbsp;John C. Welch","doi":"10.1016/j.apjon.2024.100544","DOIUrl":"10.1016/j.apjon.2024.100544","url":null,"abstract":"<div><h3>Objective</h3><p>Patients undergoing surgery, particularly patients undergoing surgery for oncology diagnoses, experience anxiety. Surgery remains the primary treatment for many common types of cancer. One promising potential intervention to alleviate anxiety in the preoperative and postoperative period is meditation, an integrative medicine intervention. However, there remains a gap in the literature regarding the effectiveness of meditation to alleviate anxiety during the perioperative time period.</p></div><div><h3>Methods</h3><p>The scoping review was conducted using the Arksey and O'Malley framework to synthesize the study findings and was reported with the Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). The review included EMBASE, PubMed, Web of Science, CINAHL Plus, Scopus, and Cochrane Review databases from 2013 through 2024. All identified articles were exported to the online systematic review software, Covidence.</p></div><div><h3>Results</h3><p>A total of 538 initial citations were identified, 415 titles and abstracts were screened, and 83 full-text articles reviewed. Six studies were finally included. The data extracted from the literature included: study purpose, study design, sample size, preoperative or postoperative timeframe, instrument to evaluate anxiety, and conclusions.</p></div><div><h3>Conclusions</h3><p>For patients undergoing oncology surgery, the perioperative period can be filled with anxiety. Guided, mindfulness, and loving-kindness meditation may be helpful in reducing anxiety, particularly in patients undergoing surgery for breast cancer during the postoperative period. However, the current literature is extremely limited. Future research should expand on the preliminary effectiveness to broader populations and carefully target the highest-risk populations for the ideal time point for interventions.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 8","pages":"Article 100544"},"PeriodicalIF":2.4,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001665/pdfft?md5=56ceb04eb5c1cb0639d570c8d8611aef&pid=1-s2.0-S2347562524001665-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141732451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, attitudes, barriers and practices concerning cancer therapy–associated oral mucositis amongst oncology nurses: A mixed methods systematic review 肿瘤科护士对癌症治疗相关口腔黏膜炎的认识、态度、障碍和做法:混合方法系统综述
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-06-21 DOI: 10.1016/j.apjon.2024.100542
Feifei Zuo , Tong Li , Ying Chen, Mianmian Wen, Huijiao Cao

Objectives

To evaluate oncology nurses' knowledge, attitudes, barriers and practices regarding the prevention and management of cancer therapy-associated oral mucositis.

Methods

A systematic review was conducted by ​mixed-methods; searches were conducted in PubMed, EMBASE, Medline, CINAHL, Cochrane Library and Web of Science databases. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines were followed for the systematic review. Searched relevant literature ​published in English between January 2000 and December 2023. The Mixed Methods Appraisal Tool was used to evaluate the quality of the studies.

Results

A total of 15 studies were included: 10 cross-sectional studies, 4 non-randomized controlled trials, and one qualitative study. This review provides an overview of the studies: nurses had limited knowledge of cancer therapy-associated oral mucositis; generally positive attitudes towards oral care; there is a slight difference in oral care practices. The main barriers of nurses' prevention and management of cancer therapy-associated oral mucositis were lack of time, lack of knowledge, and lack of staff.

Conclusions

Our results highlight the importance of training for oncology nurses regarding the management of cancer therapy-associated oral mucositis. It is suggested that oncology nurses should focus on strengthening and continuing education in oral care, adopting evidence-based practice and evaluation systems, implementing institution-specific written standards for oral care protocols, and promoting multidisciplinary team cooperation.

方法 采用混合方法进行系统综述;在 PubMed、EMBASE、Medline、CINAHL、Cochrane Library 和 Web of Science 数据库中进行检索。系统综述遵循系统综述和元分析首选报告项目(PRISMA)指南。检索了 2000 年 1 月至 2023 年 12 月间发表的相关英文文献。结果 共纳入 15 项研究:结果 共纳入 15 项研究:10 项横断面研究、4 项非随机对照试验和 1 项定性研究。本综述提供了研究概况:护士对癌症治疗相关口腔黏膜炎的了解有限;对口腔护理的态度普遍积极;口腔护理实践略有差异。护士预防和管理癌症治疗相关口腔黏膜炎的主要障碍是缺乏时间、缺乏知识和缺乏人手。建议肿瘤科护士应重点加强口腔护理方面的继续教育,采用循证实践和评估系统,实施针对特定机构的口腔护理方案书面标准,并促进多学科团队合作。
{"title":"Knowledge, attitudes, barriers and practices concerning cancer therapy–associated oral mucositis amongst oncology nurses: A mixed methods systematic review","authors":"Feifei Zuo ,&nbsp;Tong Li ,&nbsp;Ying Chen,&nbsp;Mianmian Wen,&nbsp;Huijiao Cao","doi":"10.1016/j.apjon.2024.100542","DOIUrl":"10.1016/j.apjon.2024.100542","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate oncology nurses' knowledge, attitudes, barriers and practices regarding the prevention and management of cancer therapy-associated oral mucositis.</p></div><div><h3>Methods</h3><p>A systematic review was conducted by ​mixed-methods; searches were conducted in PubMed, EMBASE, Medline, CINAHL, Cochrane Library and Web of Science databases. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines were followed for the systematic review. Searched relevant literature ​published in English between January 2000 and December 2023. The Mixed Methods Appraisal Tool was used to evaluate the quality of the studies.</p></div><div><h3>Results</h3><p>A total of 15 studies were included: 10 cross-sectional studies, 4 non-randomized controlled trials, and one qualitative study. This review provides an overview of the studies: nurses had limited knowledge of cancer therapy-associated oral mucositis; generally positive attitudes towards oral care; there is a slight difference in oral care practices. The main barriers of nurses' prevention and management of cancer therapy-associated oral mucositis were lack of time, lack of knowledge, and lack of staff.</p></div><div><h3>Conclusions</h3><p>Our results highlight the importance of training for oncology nurses regarding the management of cancer therapy-associated oral mucositis. It is suggested that oncology nurses should focus on strengthening and continuing education in oral care, adopting evidence-based practice and evaluation systems, implementing institution-specific written standards for oral care protocols, and promoting multidisciplinary team cooperation.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 8","pages":"Article 100542"},"PeriodicalIF":2.4,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001641/pdfft?md5=000a8a4640781d4f62abe387f2c81ce4&pid=1-s2.0-S2347562524001641-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141732429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved method of dilating pupils for ophthalmic exams under anesthesia (faster and easier) 改进了在麻醉状态下进行眼科检查的散瞳方法(更快、更简便)
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-06-20 DOI: 10.1016/j.apjon.2024.100543
David H. Abramson , Todd Liu , Edith Guarini , Jacquelyn Gaccione , Christina Bracken , Andrea Bobin , Angela Foerch , Melissa A. Robbins , Ricardo Dodds Rojas , Jasmine H. Francis

Objective

The pupils of children with retinoblastoma are routinely dilated pre-procedure with Tropicamide and Phenylephrine. Despite that, the pupil constricts once general anesthesia begins. The aim of this study is to see if adding Ketorolac to the regular dilating drops given pre-procedure shortens the length of anesthesia.

Methods

Retrospective comparison of time under anesthesia for two groups of retinoblastoma children receiving anesthesia for examination under anesthesia: one group (January 1, 2019 to October 1, 2022) had been dilated with Tropicamide 1% and Phenylephrine 2.5% while the second group (October 2, 2022 to July 1, 2023) was dilated with a combination drop using those drugs with topical Ketorolac 0.5% and Proparacaine 0.5%.

Results

Average anesthesia time for patients who received the older two-drug combination was 25 minutes vs. 16 minutes (36% reduction in exposure time) for those who received the newer four-drug combination (9 minutes less anesthesia) (P < 0.001).

Conclusions

The use of a combined dilating drop that incorporated Tropicamide 1%, Phenylephrine 2.5%, Proparacaine 0.5% and Ketorolac 0.5% significantly shortened the time for exams under anesthesia for children with retinoblastoma because the pupil remained dilated after anesthesia induction with Sevoflurane. Using this combined drop, children will receive 5–10 hours less anesthesia during their treatment for retinoblastoma and staff will have more than 150 hours of fewer exposure to anesthetic gasses. In addition, far fewer drops are necessary pre-anesthesia, minimizing trauma to the children and families.

目的视网膜母细胞瘤患儿在术前常规使用托吡卡胺和苯肾上腺素散瞳。尽管如此,一旦开始全身麻醉,瞳孔就会收缩。本研究旨在了解在术前常规散瞳滴剂中加入酮咯酸是否会缩短麻醉时间。方法回顾性比较两组接受麻醉检查的视网膜母细胞瘤患儿的麻醉时间:一组(2019 年 1 月 1 日至 2022 年 10 月 1 日)用 1%托吡卡胺和 2.5%,而第二组(2022 年 10 月 2 日至 2023 年 7 月 1 日)则在使用上述药物的基础上联合滴用 0.5%酮咯酸和 0.5%丙美卡因进行扩张。结果 使用较早的两药联合疗法的患者的平均麻醉时间为 25 分钟,而使用较新的四药联合疗法的患者的平均麻醉时间为 16 分钟(缩短了 36%)(麻醉时间缩短了 9 分钟)(P < 0.001)。结论使用含有 1%托吡卡胺、2.5% 苯肾上腺素、0.5% 丙美卡因和 0.5%酮咯酸的复合散瞳滴剂可显著缩短视网膜母细胞瘤患儿的麻醉检查时间,因为在使用七氟醚诱导麻醉后瞳孔仍处于散大状态。使用这种复合滴剂,儿童在视网膜母细胞瘤治疗期间的麻醉时间将减少 5-10 小时,工作人员接触麻醉气体的时间将减少 150 小时以上。此外,麻醉前所需的滴剂也会大大减少,从而最大程度地减少对儿童和家人的创伤。
{"title":"Improved method of dilating pupils for ophthalmic exams under anesthesia (faster and easier)","authors":"David H. Abramson ,&nbsp;Todd Liu ,&nbsp;Edith Guarini ,&nbsp;Jacquelyn Gaccione ,&nbsp;Christina Bracken ,&nbsp;Andrea Bobin ,&nbsp;Angela Foerch ,&nbsp;Melissa A. Robbins ,&nbsp;Ricardo Dodds Rojas ,&nbsp;Jasmine H. Francis","doi":"10.1016/j.apjon.2024.100543","DOIUrl":"https://doi.org/10.1016/j.apjon.2024.100543","url":null,"abstract":"<div><h3>Objective</h3><p>The pupils of children with retinoblastoma are routinely dilated pre-procedure with Tropicamide and Phenylephrine. Despite that, the pupil constricts once general anesthesia begins. The aim of this study is to see if adding Ketorolac to the regular dilating drops given pre-procedure shortens the length of anesthesia.</p></div><div><h3>Methods</h3><p>Retrospective comparison of time under anesthesia for two groups of retinoblastoma children receiving anesthesia for examination under anesthesia: one group (January 1, 2019 to October 1, 2022) had been dilated with Tropicamide 1% and Phenylephrine 2.5% while the second group (October 2, 2022 to July 1, 2023) was dilated with a combination drop using those drugs with topical Ketorolac 0.5% and Proparacaine 0.5%.</p></div><div><h3>Results</h3><p>Average anesthesia time for patients who received the older two-drug combination was 25 minutes vs. 16 minutes (36% reduction in exposure time) for those who received the newer four-drug combination (9 minutes less anesthesia) (<em>P</em> &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>The use of a combined dilating drop that incorporated Tropicamide 1%, Phenylephrine 2.5%, Proparacaine 0.5% and Ketorolac 0.5% significantly shortened the time for exams under anesthesia for children with retinoblastoma because the pupil remained dilated after anesthesia induction with Sevoflurane. Using this combined drop, children will receive 5–10 hours less anesthesia during their treatment for retinoblastoma and staff will have more than 150 hours of fewer exposure to anesthetic gasses. In addition, far fewer drops are necessary pre-anesthesia, minimizing trauma to the children and families.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 8","pages":"Article 100543"},"PeriodicalIF":2.4,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001653/pdfft?md5=bb560522586aa9eb111dbc733186e5ad&pid=1-s2.0-S2347562524001653-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141607766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the role of complementary therapy in enhancing quality of life for cancer survivors: A nursing perspective 探索辅助疗法在提高癌症幸存者生活质量方面的作用:护理视角
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-06-19 DOI: 10.1016/j.apjon.2024.100541
Kazuko Onishi
{"title":"Exploring the role of complementary therapy in enhancing quality of life for cancer survivors: A nursing perspective","authors":"Kazuko Onishi","doi":"10.1016/j.apjon.2024.100541","DOIUrl":"10.1016/j.apjon.2024.100541","url":null,"abstract":"","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 8","pages":"Article 100541"},"PeriodicalIF":2.4,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S234756252400163X/pdfft?md5=1fe85d8c7fd052bfd41b309cddee15aa&pid=1-s2.0-S234756252400163X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141728584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asia-Pacific Journal of Oncology Nursing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1